Allows enterprise leaders to compare features like capability, safety, affordability, and speed
across 90+ AI use cases and 20+ industries

Credo AI Launches Model Trust Scores to Enable Secure Enterprise AI Model Selection

Revolutionary AI predicts enterprise demand, maps high-value connections, and automates decision-making with unprecedented accuracy

Collective[i] Launches AI Model Trained to Forecast Business and Economic Outcomes

Credo AI

Akbank, a pioneer of digital transformation in the Turkish banking sector, has announced its “Responsible Artificial Intelligence Manifesto.” Prepared in partnership with LotusAI, the manifesto outlines the bank’s commitment to utilizing artificial intelligence (AI) in a human-centric, ethical, and sustainable manner.

Akbank and LotusAI Unveil Akbank’s Responsible Artificial Intelligence Manifesto

Akbank Unveils Its Responsible Artificial Intelligence Manifesto

Lotus AI

Search Copilot is powered by Read AI’s new Free Agent technology, capable of seamlessly unifying data and capturing insights across open and closed platforms.


Read AI Launches Search Copilot, an Industry-First AI Tool for Cross-Platform Search and Discovery—at No Cost

Search Copilot is powered by Read AI’s new Free Agent technology, capable of seamlessly unifying data and capturing insights across open and closed platforms
‍

Read AI

Inaugural global university competition focused on advancing secure, trusted AI-assisted software development.

Amazon Nova AI Challenge accelerating the field of generative AI

Amazon Nova

Personal AI and NVIDIA Riva: Bringing Voice-to-Voice AI Personas to Life for Small Businesses

Personal AI

AI21 Introduces Maestro, the World's First AI Planning and Orchestration System Built for the Enterprise

AI21 is leading the shift from LLMs and Reasoning models to planning AI systems. Maestro increases the accuracy of GPT-4o and Claude Sonnet 3.5 by up to 50% on complex, multi-requirement tasks, transforming AI from an unpredictable tool to a trustworthy system.

AI21

Zensai Unveils The Human Success Score: "The Strava for Work" at HumanX 2025 to Predict Future Team Performance and Success

The Human Success Score is the first and only predictive metric in Zensai's Human Success Platform that communicates team effectiveness to future business performance with measurable impact.

Zensai

Plus and TIER IV Partner to Advance Autonomy 2.0 in Japan, Starting with Driverless Trucks

A strategic partnership to accelerate the development and deployment of advanced autonomous driving solutions, Autonomy 2.0, in Japan, starting with Level 4 autonomous trucks on Japan's expressways.

Plus Tier IV

Former Vice President Kamala Harris and Nuno Sebastião to Host Fireside Chat at HumanX

Former Vice President Kamala Harris and Nuno Sebastião, Chairman of Feedzai, will headline this year’s event. The two leaders will host a fireside chat on advancing artificial intelligence (AI) and its potential to build a fair, secure, and inclusive future.

Kamala Harris and Nuno Sebastião to Host Fireside Chat at HumanX

Kamala Harris Announcement

HumanX Set to Become World’s Most Important AI Conference; Launches Intimate Sessions with Tech Leaders

HumanX unveiled its full agenda, featuring on-stage presentations, fireside chats, and panels with some of the world’s foremost AI builders, such as OpenAI, Anthropic, Databricks, Hugging Face, Mistral, and more.

HumanX Launches Intimate Sessions 

HumanX Interactive Sessions

Unique Secures USD $30 Million Series A to Pioneer Agentic AI Workforce in Financial Services

Sama will announce its new framework for multi-modal agentic AI that will serve multiple industries.

Unique Secures USD $30 Million Series A

Unique AI Funding

Aging and Disease | Insilico unveils a robotics lab-driven study highlighting TNIK inhibition as a promising anti-aging strategy

A groundbreaking study led by researchers at Insilico Medicine has revealed the potential of TNIK inhibition as an innovative anti-aging strategy. Using an AI-driven robotics laboratory , the team identified INS018_055 (Rentosertib) —a potent small-molecule TNIK previously developed by Insilico Medicine, which has already advanced into clinical trials for idiopathic pulmonary fibrosis (IPF)—as a highly effective senomorphic agent capable of mitigating cellular senescence. The findings were published in Aging and Disease.

Insilico Medicine unveils a robotics lab-driven study

Insilico unveils a robotics lab-driven study

Sama Launches Agentic Capture, a Robust Data Capture Framework for Multi-Modal Agentic AI

Sama Launches Agentic Capture

Meet Gem-E: An AI Outbound Agent Powered by Signals that Generate Pipeline

AI Sales Agents That'll Make you Hire More Humans

User Gems

HumanX Raises $6M to Launch the Premier Community for AI, Setting Agenda for Inaugural Gathering in March 2025

With Funding from Primary Ventures, Foundation Capital, FPV Ventures and a16z, HumanX is Focused on Distilling AI Complexity into Actionable Insights, Strategy and Tactics for the Decisionmakers in Corporations and Governments

Former Vice President Kamala Harris and Nuno Sebastião to Host Fire...